ALZ-NET is the first network developed specifically for new FDA-approved Alzheimer's treatments, collecting real-world evidence on drug effectiveness and side effects over a long period of time. The ...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease (AD) and other ...
NEWBERRY, S.C. (WCSC) - The July heat isn’t stopping hundreds of cyclists from pedaling from one side of South Carolina to the other over the next three days. Their goal is to support those fighting ...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from ...
WILL KICK START THEIR THREE DAY JOURNEY ACROSS SOUTH CAROLINA. IT’S THE 16TH ANNUAL RIDE TO END ALS, RAISING MONEY AND AWARENESS FOR THE STATE CHAPTER OF THE ALZHEIMER’S ASSOCIATION. JANE ROBELOT ...
NEW YORK, April 2, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative treatments for unmet medical needs, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results